Uno degli obiettivi principali di Life4me+ è quello di prevenire nuovi casi di HIV e altre infezioni sessualmente trasmissibili, epatite C e tubercolosi.

L'app aiuta a stabilire una comunicazione anonima tra i medici e le persone sieropositive. Ti consente di organizzare comodamente l'orario di assunzione dei farmaci e di impostare promemoria nascosti e personalizzati.

Tutte le notizie / Febbraio 2017

Archivio

✕

22 febbraio 2017

3841

HIV Conserv vaccine achieves long-term viral suppression in 38% of trial recipients

HIV Conserv vaccine achieves long-term viral suppression in 38% of trial recipients

For the first time, an “HIV Conserv” vaccine has been shown to achieve long-term viral suppression in a large minority (38%) of recipients who were taken off antiretroviral therapy (ART). That is, the virus is still present, but does not rebound after stopping ART.

21 febbraio 2017

3698

Study: No evidence of accelerated brain aging in people living with HIV who take ART

Study: No evidence of accelerated brain aging in people living with HIV who take ART

According to a study run in Amsterdam and London, magnetic resonance imaging (MRI) and cognitive testing showed no evidence of accelerated brain aging in people living with HIV who are also on antiretroviral therapy (ART).

21 febbraio 2017

4321

Canada approves rapid hepatitis C antibody test

Canada approves rapid hepatitis C antibody test

Health Canada has approved the sale and use of Orasure Technologies' OraQuick HCV rapid antibody test, which is a point-of-care test for screening patients for exposure to hepatitis C (HCV). The test, which has been approved in other wealthy countries, uses a drop of blood ...

21 febbraio 2017

4077

Nanotechnology based gene editing to eradicate HIV brain reservoir in drug abusers

Nanotechnology based gene editing to eradicate HIV brain reservoir in drug abusers

Scientists are studying new therapies that can eradicate HIV infection and mitigate the damaging effects that opiate drug addiction has on the central nervous system. Drug abuse is a significant risk factor for HIV infection, and in combination, they can have a devastating ...

21 febbraio 2017

5299

Merck: Doravirine (MK-1439) is safe and effective, Phase 3 trials show

Merck: Doravirine (MK-1439) is safe and effective, Phase 3 trials show

Merck & Co. (MRK) has announced positive results following Phase 3 clinical trials of its anti-HIV drug, doravirine (MK-1439). According to company officials, a 48-week test on previously untreated adults showed that the drug is safe and just as effective as a ritonavir-boosted ...

20 febbraio 2017

4261

Study: Oral PrEP works as well in women with abnormal vaginal microbiota

Study: Oral PrEP works as well in women with abnormal vaginal microbiota

Previous research suggested that an anti-HIV vaginal gel might not work as effectively in women with bacterial vaginosis and other imbalances in the vaginal microbiome, but a recent study presented by Renee Heffron of the University of Washington showed that daily oral pre-exposure ...

20 febbraio 2017

3920

Civil society groups challenge patents on Hepatitis C medicines

Civil society groups challenge patents on Hepatitis C medicines

Civil society groups in India and Argentina have filed five new challenges to patents on Hepatitis C drugs. If successful, these challenges would make Hepatitis C drugs affordable for millions of patients by enabling the production and distribution of generic versions of ...

18 febbraio 2017

4049

Public health professionals argue: 18% decline in HIV incidence is not enough

Public health professionals argue: 18% decline in HIV incidence is not enough

The U.S. Centers for Disease Control and Prevention (CDC) have reported new US HIV incidence estimates for the years 2008 to 2014. Using a new method for estimating the numbers based on diagnostic and CD4 cell level at the time of diagnosis, the CDC found that HIV incidence ...

17 febbraio 2017

3955

California: intentional transmission of HIV may soon no longer be a felony

California: intentional transmission of HIV may soon no longer be a felony

A California law that made the intentional transmission of HIV a felony could soon be changed. In 1988, it was made a felony for people who were aware they were HIV-positive to donate blood. In 1998, it was made a felony to engage in unprotected sex with the intention of ...

17 febbraio 2017

4398

TB drug IPT found to reduce HIV patients' risk of death 37%

TB drug IPT found to reduce HIV patients' risk of death 37%

According to the Temprano ANRS 12136 study, people living with HIV who took a six-month course of isoniazid preventative treatment (IPT) reduced their risk of death by 37% over an average follow-up period of 4.5 years.

1 2 3 4 5